Form 4: 89bio, Inc. Executive Harry H. Mansbach Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Chief Medical Officer of 89bio, Inc., Harry H. Mansbach, reports the disposition of 1,046 shares of common stock to cover tax obligations related to vesting restricted stock units.
Summary
- On August 17, 2024, Harry H. Mansbach, Chief Medical Officer of 89bio, Inc., disposed of 1,046 shares of common stock.
- The transaction was executed to cover the estimated tax withholding obligation associated with the vesting of restricted stock units.
- Following the transaction, Mansbach directly owns 157,391 shares of 89bio, Inc. common stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing related to stock transactions for tax purposes, indicating a neutral sentiment.
Industry Context
This filing is a routine disclosure related to executive compensation and tax obligations, common in publicly traded companies.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is related to tax obligations of an executive.
Key Dates
| Date | Description |
|---|---|
| 08/17/2024 | Date of transaction: Harry H. Mansbach disposed of 1,046 shares of common stock. |
| 08/19/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.